226 related articles for article (PubMed ID: 25211284)
1. Spiramycin/cotrimoxazole versus pyrimethamine/sulfonamide and spiramycin alone for the treatment of toxoplasmosis in pregnancy.
Valentini P; Buonsenso D; Barone G; Serranti D; Calzedda R; Ceccarelli M; Speziale D; Ricci R; Masini L
J Perinatol; 2015 Feb; 35(2):90-4. PubMed ID: 25211284
[TBL] [Abstract][Full Text] [Related]
2. Role of spiramycin/cotrimoxazole association in the mother-to-child transmission of toxoplasmosis infection in pregnancy.
Valentini P; Annunziata ML; Angelone DF; Masini L; De Santis M; Testa A; Grillo RL; Speziale D; Ranno O
Eur J Clin Microbiol Infect Dis; 2009 Mar; 28(3):297-300. PubMed ID: 18716804
[TBL] [Abstract][Full Text] [Related]
3. Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial.
Mandelbrot L; Kieffer F; Sitta R; Laurichesse-Delmas H; Winer N; Mesnard L; Berrebi A; Le Bouar G; Bory JP; Cordier AG; Ville Y; Perrotin F; Jouannic JM; Biquard F; d'Ercole C; Houfflin-Debarge V; Villena I; Thiébaut R;
Am J Obstet Gynecol; 2018 Oct; 219(4):386.e1-386.e9. PubMed ID: 29870736
[TBL] [Abstract][Full Text] [Related]
4. Congenital toxoplasmosis: efficacy of maternal treatment with spiramycin alone.
Vergani P; Ghidini A; Ceruti P; Strobelt N; Spelta A; Zapparoli B; Rescaldani R
Am J Reprod Immunol; 1998 May; 39(5):335-40. PubMed ID: 9602252
[TBL] [Abstract][Full Text] [Related]
5. Assessment of laboratory methods used in the diagnosis of congenital toxoplasmosis after maternal treatment with spiramycin in pregnancy.
Rodrigues IM; Costa TL; Avelar JB; Amaral WN; Castro AM; Avelino MM
BMC Infect Dis; 2014 Jun; 14():349. PubMed ID: 24961630
[TBL] [Abstract][Full Text] [Related]
6. Unresolved questions about the most successful known parasite.
Ajzenberg D
Expert Rev Anti Infect Ther; 2011 Feb; 9(2):169-71. PubMed ID: 21342063
[TBL] [Abstract][Full Text] [Related]
7. Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France.
Gilbert RE; Gras L; Wallon M; Peyron F; Ades AE; Dunn DT
Int J Epidemiol; 2001 Dec; 30(6):1303-8. PubMed ID: 11821334
[TBL] [Abstract][Full Text] [Related]
8. Role of spiramycin in prevention of fetal toxoplasmosis.
Avci ME; Arslan F; Çiftçi Ş; Ekiz A; Tüten A; Yildirim G; Madazli R
J Matern Fetal Neonatal Med; 2016; 29(13):2073-6. PubMed ID: 26365472
[TBL] [Abstract][Full Text] [Related]
9. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii.
Gilbert R; Gras L;
BJOG; 2003 Feb; 110(2):112-20. PubMed ID: 12618153
[TBL] [Abstract][Full Text] [Related]
10. Cotrimoxazole for prenatal treatment of congenital toxoplasmosis?
Derouin F; Jacqz-Aigrain E; Thulliez P; Couvreur J; Leport C
Parasitol Today; 2000 Jun; 16(6):254-6. PubMed ID: 10827434
[TBL] [Abstract][Full Text] [Related]
11. Treatment of toxoplasmosis in pregnancy: concentrations of spiramycin and neospiramycin in maternal serum and amniotic fluid.
Gratzl R; Sodeck G; Platzer P; Jäger W; Graf J; Pollak A; Thalhammer T
Eur J Clin Microbiol Infect Dis; 2002 Jan; 21(1):12-6. PubMed ID: 11913495
[TBL] [Abstract][Full Text] [Related]
12. [Postnatal follow-up of infants born to mothers with certain Toxoplasma gondii infection: evaluation of prenatal management].
Di Carlo P; Mazzola A; Romano A; Schimmenti MG; Colicchia P; Bellipanni P; Titone L
Infez Med; 2005 Jun; 13(2):72-8. PubMed ID: 16220026
[TBL] [Abstract][Full Text] [Related]
13. A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in Humans.
Wei HX; Wei SS; Lindsay DS; Peng HJ
PLoS One; 2015; 10(9):e0138204. PubMed ID: 26394212
[TBL] [Abstract][Full Text] [Related]
14. Management of Toxoplasma gondii infection during pregnancy.
Montoya JG; Remington JS
Clin Infect Dis; 2008 Aug; 47(4):554-66. PubMed ID: 18624630
[TBL] [Abstract][Full Text] [Related]
15. Congenital toxoplasmosis and prenatal care state programs.
Avelino MM; Amaral WN; Rodrigues IM; Rassi AR; Gomes MB; Costa TL; Castro AM
BMC Infect Dis; 2014 Jan; 14():33. PubMed ID: 24438336
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and treatment of congenital toxoplasmosis].
Koskiniemi M
Duodecim; 1993; 109(14):1260-4. PubMed ID: 8062703
[No Abstract] [Full Text] [Related]
17. Primary Toxoplasma gondii infection in a pregnant human immunodeficiency virus-infected woman.
D'Offizi G; Topino S; Anzidei G; Frigiotti D; Narciso P
Pediatr Infect Dis J; 2002 Oct; 21(10):981-2. PubMed ID: 12400531
[TBL] [Abstract][Full Text] [Related]
18. Toxoplasmosis in pregnancy.
Wong SY; Remington JS
Clin Infect Dis; 1994 Jun; 18(6):853-61; quiz 862. PubMed ID: 8086543
[No Abstract] [Full Text] [Related]
19. Spyramicine and Trimethoprim-Sulfamethoxazole Combination to Prevent Mother-To-Fetus Transmission of Toxoplasma gondii Infection in Pregnant Women: A 28-Years Single-center Experience.
Buonsenso D; Pata D; Turriziani Colonna A; Iademarco M; De Santis M; Masini L; Conti G; Molle F; Baldascino A; Acampora A; Luciano R; Gallini F; Valentini P
Pediatr Infect Dis J; 2022 May; 41(5):e223-e227. PubMed ID: 35175992
[TBL] [Abstract][Full Text] [Related]
20. Toxoplasmosis in pregnancy: prevention, screening, and treatment.
Paquet C; Yudin MH;
J Obstet Gynaecol Can; 2013 Jan; 35(1):78-81. PubMed ID: 23343802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
